Exploring the weight loss drug Ozempic and the complexities of weight stigma and diet culture. Discussion on the shift towards patient-centered care in health. Addressing disparities in access and benefits of Ozempic. Societal pressures on weight loss and exercise, with caution on medication use. Considerations before using weight loss medications, finding a weight-inclusive doctor, and assessing risks.

Lili Zarghami, a writer who detailed her experience with GLP-1 weight loss medication, joins Dr. Mara Gordon, a weight-neutral physician, to discuss the troubling interplay between diet culture and health. They delve into the economics of weight loss drugs, highlighting how societal pressures exacerbate body image issues. The conversation also critiques fatphobia and the medicalization of obesity, urging a compassionate approach to health. Together, they illuminate the emotional and psychological costs of stigma, advocating for broader understanding in healthcare.

Mara Gordon, a family physician and advocate for size-inclusive medicine, dives deep into the shortcomings of the healthcare system regarding fatphobia. She discusses how traditional practices often neglect the needs of individuals in larger bodies and emphasizes the importance of patient-centered care. Mara also highlights the launch of an initiative for weight-inclusive medicine and navigates the complexities of prediabetes, arguing for a more personalized healthcare approach. The conversation is both enlightening and a call to action for better advocacy in medical spaces.